Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed B-cell NHL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchTemporarily pausedNCT04697290
What this trial is testing

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Beijing Tsinghua Chang Gung Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00058305
What this trial is testing

Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Genmab 264
Not applicableEnrolling By InvitationNCT05332054
What this trial is testing

Long-Term Follow-up Study

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+7 more
Caribou Biosciences, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Study completedNCT00796731
What this trial is testing

SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNon-Hodgkin
Sanofi 77
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477366
What this trial is testing

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-Cell Non-Hodgkin Lymphoma
ImmunityBio, Inc. 20
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT06323525
What this trial is testing

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Chinese PLA General Hospital 30
Very early researchUnknownNCT04412174
What this trial is testing

GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02593123
What this trial is testing

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

Who this might be right for
Hodgkin's LymphomaLymphoid LeukemiaLymphoma+15 more
Virginia Commonwealth University 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607925
What this trial is testing

Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020015
What this trial is testing

TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Takeda 27
Early research (Phase 1)Looking for participantsNCT06180174
What this trial is testing

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
B Cell LymphomaNon Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06565689
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Excyte Biopharma Ltd 48
Early research (Phase 1)Looking for participantsNCT06859008
What this trial is testing

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Diffuse Large B-Cell Lymphoma+16 more
City of Hope Medical Center
Next Page
37